CLINICAL_TRIALS
trial_result
· 2025-12-05
Clinical Trial Update: A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE) [Phase 2]
Summary
A Phase 2 study of Zetomipzomib (KZR-616) in patients with active lupus nephritis has been terminated, and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kezar Life Sciences, Inc. | Conditions: Lupus Nephritis | Phase 2 | Status: TERMINATED | Results posted: 2025-12-05